Effect of new tuberculosis diagnostic technologies on community-based intensified case finding: a multicentre randomised controlled trial

The Lancet Infectious Diseases

Volumn 17, Issue 4, 2017, Pages 441-450

  Calligaro, Gregory L ^a   Zijenah, Lynn S ^a   Peter, Jonathan G ^a   Theron, Grant ^a,b   Buser, Virginia ^a   McNerney, Ruth ^a   Bara, Wilbert ^c   Bandason, Tsitsi ^d   Govender, Ureshnie ^a   Tomasicchio, Michele ^a   Smith, Liezel ^a   Mayosi, Bongani M ^e   Dheda, Keertan ^a  

^a UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^b UNIVERSITY OF STELLENBOSCH   (South Africa)

^c MINISTRY OF HEALTH AND CHILD CARE   (Zimbabwe)

^d Biomedical Training Research Institute   (Zimbabwe)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOARABINOMANNAN;

ADULT; ARTICLE; CASE FINDING; COMMUNITY; CONTROLLED STUDY; COUGHING; DIAGNOSIS RELATED GROUP; DIAGNOSTIC TEST; FEMALE; HEMOPTYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOUTH AFRICA; SPUTUM CULTURE; SPUTUM SMEAR; TUBERCULOSIS; URINALYSIS; ZIMBABWE; AFRICA SOUTH OF THE SAHARA; CLINICAL TRIAL; DEVELOPING COUNTRY; ISOLATION AND PURIFICATION; MYCOBACTERIUM TUBERCULOSIS; OUTPATIENT DEPARTMENT; PREVALENCE; SENSITIVITY AND SPECIFICITY; SPUTUM; STATISTICS AND NUMERICAL DATA; TIME FACTOR; TRANSMISSION;

ADULT; AFRICA SOUTH OF THE SAHARA; AMBULATORY CARE FACILITIES; DEVELOPING COUNTRIES; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HUMANS; MALE; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; SENSITIVITY AND SPECIFICITY; SPUTUM; TIME FACTORS; TUBERCULOSIS;

EID: 85008445061     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(16)30384-X     Document Type: Article

References (27)

1. 1 Dheda, K, Barry, CE 3rd, Maartens, G, Tuberculosis. Lancet 387 (2016), 1211–1226.
2. 2 McNerney, R, Daley, P, Towards a point-of-care test for active tuberculosis: obstacles and opportunities. Nat Rev Microbiol 9 (2011), 204–213.
3. 3 WHO. Systematic screening for active tuberculosis: principles and recommendations. http://www.who.int/tb/publications/Final_TB_Screening_guidelines.pdf, 2013 (accessed April 1, 2015).
4. 4 Golub, JE, Mohan, CI, Comstock, GW, Chaisson, RE, Active case finding of tuberculosis: historical perspective and future prospects. Int J Tuberc Lung Dis 9 (2005), 1183–1203.
5. 5 Boehme, CC, Nicol, MP, Nabeta, P, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 377 (2011), 1495–1505.
6. 6 Peter, J, Green, C, Hoelscher, M, Mwaba, P, Zumla, A, Dheda, K, Urine for the diagnosis of tuberculosis: current approaches, clinical applicability, and new developments. Curr Opin Pulm Med 16 (2010), 262–270.
7. 7 Shah, M, Hanrahan, C, Wang, ZY, et al. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults. Cochrane Database Syst Rev, 5, 2016 Cd011420.
8. 8 Theron, G, Zijenah, L, Chanda, D, et al. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial. Lancet 383 (2014), 424–435.
9. 9 Peter, JG, Zijenah, LS, Chanda, D, et al. Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial. Lancet 387 (2016), 1187–1197.
10. 10 Abed Al-Darraji, HA, Abd Razak, H, Ng, KP, Altice, FL, Kamarulzaman, A, The diagnostic performance of a single GeneXpert MTB/RIF assay in an intensified tuberculosis case finding survey among HIV-infected prisoners in Malaysia. PLoS One, 8, 2013, e73717.
11. 11 Dierberg, KL, Dorjee, K, Salvo, F, et al. improved detection of tuberculosis and multidrug-resistant tuberculosis among Tibetan refugees, India. Emerg Infect Dis 22 (2016), 463–468.
12. 12 John, S, Gidado, M, Dahiru, T, Fanning, A, Codlin, AJ, Creswell, J, Tuberculosis among nomads in Adamawa, Nigeria: outcomes from two years of active case finding. Int J Tuberc Lung Dis 19 (2015), 463–468.
13. 13 Khanal, S, Baral, S, Shrestha, P, et al. Yield of intensified tuberculosis case-finding activities using Xpert((R)) MTB/RIF among risk groups in Nepal. Public Health Action 6 (2016), 136–141.
14. 14 Lorent, N, Choun, K, Thai, S, et al. Community-based active tuberculosis case finding in poor urban settlements of Phnom Penh, Cambodia: a feasible and effective strategy. PLoS One, 9, 2014, e92754.
15. 15 Peter, JG, Theron, G, Singh, N, Singh, A, Dheda, K, Sputum induction to aid the diagnosis of smear-negative or sputum-scarce TB in adults from a HIV-endemic setting. Eur Respir J 43 (2013), 185–194.
16. 16 Getahun, H, Kittikraisak, W, Heilig, CM, et al. Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies. PLoS Med, 8, 2011, e1000391.
17. 17 Bassett, IV, Wang, B, Chetty, S, et al. Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa. Clin Infect Dis 51 (2010), 823–829.
18. 18 Cruciani, M, Scarparo, C, Malena, M, Bosco, O, Serpelloni, G, Mengoli, C, Meta-analysis of BACTEC MGIT 960 and BACTEC 460 TB, with or without solid media, for detection of mycobacteria. J Clin Microbiol 42 (2004), 2321–2325.
19. 19 Kranzer, K, Houben, RM, Glynn, JR, Bekker, LG, Wood, R, Lawn, SD, Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis. Lancet Infect Dis 10 (2010), 93–102.
20. 20 Hochberg, Y, Benjamini, Y, More powerful procedures for multiple significance testing. Stat Med 9 (1990), 811–818.
21. 21 Viera, AJ, Garrett, JM, Understanding interobserver agreement: the kappa statistic. Fam Med 37 (2005), 360–363.
22. 22 Metcalfe, JZ, Makumbirofa, S, Makamure, B, et al. Suboptimal specificity of Xpert MTB/RIF among treatment-experienced patients. Eur Respir J 45 (2015), 1504–1506.
23. 23 Corbett, EL, Bandason, T, Duong, T, et al. Comparison of two active case-finding strategies for community-based diagnosis of symptomatic smear-positive tuberculosis and control of infectious tuberculosis in Harare, Zimbabwe (DETECTB): a cluster-randomised trial. Lancet 376 (2010), 1244–1253.
24. 24 Peter, JG, Theron, G, Zyl-Smit, R, Haripersad, A, Mottay, L, Kraus, S, Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients. Eur Respir J 40 (2012), 1211–1220.
25. 25 Behr, MA, Warren, SA, Salamon, H, et al. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 353 (1999), 444–449.
26. 26 Tostmann, A, Kik, SV, Kalisvaart, NA, et al. Tuberculosis transmission by patients with smear-negative pulmonary tuberculosis in a large cohort in the Netherlands. Clin Infect Dis 47 (2008), 1135–1142.
27. 27 Wood, R, Middelkoop, K, Myer, L, et al. Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control. Am J Respir Crit Care Med 175 (2007), 87–93.